Aletheia BioTherapeutics, LLC — Form D
Aletheia BioTherapeutics, LLC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-24. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-01-24
- Form: D
- Accession: 0001553350-19-000078
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Investors: 3
- Date of first sale: 2018-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-331291
Issuer
- Name: Aletheia BioTherapeutics, LLC
- CIK: 0001765522
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 17 STATE STREET, 3RD FLOOR, NEW YORK, NY, 10004
- Phone: 2125097708
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Laurie Playtek | Executive Officer | New York, NY |
| Thomas Barton | Director | New York, NY |
| Laurie Platek | Director | New York, NY |
| Laurie Platek | Executive Officer | New York, NY |
| Michael Muhonen | Director | New York, NY |
| Chrystyna Bedrij | Executive Officer | New York, NY |
Other filings by this issuer (3)
More